36Kr English

The robotic Apex Hand comes unusually close to matching its human counterpart.

After inking an USD 8.4 billion deal with BMS, the founder says Biokin’s next chapter is about efficiency, innovation, and going global.

The insurer is ramping up investments even as earnings weaken and its shares trade at a discount to peers.

With Haidilao and Xiabu Xiabu trading at depressed valuations, Banu’s listing faces questions over growth, governance, and consumer demand.

CEO William Li says the EV maker is emerging from a crisis deeper than in 2019, but now has the maturity to weather it.

As companion robots debut, investors question whether they are useful appliances or pricey toys for the middle class.

Robotics companies are accelerating launch cycles and crossing into each other’s categories, tapping innovation to keep growth alive in a crowded market.

The two firms are shifting focus from portable power to home storage, betting that easier installation will win over consumers.